Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,519 total articles
Ascendis (ASND) has moved from development to commercialization with FDA approval and early Q2 2026 availability of its once-weekly TransCon CNP product for achondroplasia. The company already has commercial products generating meaningful revenue and a $120M buyback program; we initiate a buy for a long-term trade that targets durable market adopti…
Energy Transfer (ET) posted healthy Q1 distributable cash flow and continues to support its $1.35 annual dividend. With an enterprise value of $135.8B, EV/EBITDA around 8.7x and a market cap near $66.5B, the stock offers yield plus upside as midstream fundamentals remain stable. This trade idea targets $21.50 with a stop at $18.25 and a 180-trading…
Microsoft is trading at ~$415 with a market cap north of $3 trillion, healthy free cash flow of ~$73B, and ROE above 30%. Near-term margin pressure from aggressive capital spending is a headwind, but increased capex to capture AI and cloud demand is defensible and could be the catalyst for further multiple expansion over the next 180 trading days. …
LSB Industries appears to be compounding value through steady margin execution even as the market focuses on headline volumes. With operational leverage, tighter cost control and improving product mix, LSB is an asymmetric trade for traders willing to back execution. This is a swing trade idea with a clear entry, stop and target tied to horizon-bas…
Palantir is expensive today but its fundamentals are strong: $4.5B revenue (56% YoY), $1.6B net income and hefty margins with meaningful free cash flow. This trade idea targets a valuation-driven entry where the stock falls to roughly 93x trailing earnings ($88.35). The plan is a long trade with a clear stop at $72.00 and a target of $150.00 over ~…
Rocket Lab has the operational momentum and a $2.2B backlog to justify a premium — but the stock already reflects aggressive expectations. We lay out a mid-term (45 trading days) long trade that bets on a SpaceX IPO-led rerating and continued defense wins, with a clear entry, stop and target and a balanced risk map.
Vista Energy (VIST) is a buy at current levels. The company prints healthy margins and production momentum, trades at a $7.0B market cap with a single-digit P/E, and technicals show constructive momentum. With a likely acceleration in 2026 from integration tailwinds and operational levers, the trade aims for a measured upside to $90 with a $65 stop…
Zumiez (ZUMZ) looks actionable on a mid-term long. The retailer combines a clean balance sheet, positive free cash flow ($42.4M), and attractive valuation metrics (EV/EBITDA 7.5; P/FCF 9.8) with technical momentum around $25.16. I recommend a swing trade with clear entry, stop and target—position size to risk tolerance.
Sociedad Química y Minera de Chile (SQM) just cleared a technical and fundamental hurdle: shares jumped into the mid-$80s on strong Q1 tone and improving lithium supply signals. At a market cap of ~$22.9B, a sharp upgrade in near-term demand and supply tightness justifies a tactical long. This trade idea lays out an entry at $84.00, a stop at $74.0…
Micron has entered a rare structural squeeze as AI demand for high-bandwidth memory and flash storage outstrips capacity. Momentum is strong, fundamentals justify ownership, but valuation and cyclicality require strict risk management. This trade targets a mid-term bounce to $1,400 with a $820 stop.
Micron just crossed the $1 trillion mark and remains supported by AI-driven demand for high-bandwidth memory. Fundamentals (free cash flow roughly $10.3B, ROE ~33%) and near-term supply tightness make further upside likely, but elevated multiples and a stretched RSI increase the risk of sharp pullbacks. This trade lays out a long plan with precise …
CorMedix (CRMD) looks set for choppy action in the coming weeks, but the shares trade at a valuation that materially understates current revenue power and free cash flow. We recommend a long trade for investors willing to tolerate short-term downside: entry $8.45, stop $6.00, target $20.00, horizon long term (180 trading days).
Energy Services of America (ESOA) is upgraded to a tactical long. The company's $280.7M backlog, exposure to gas distribution and industrial electrification work, and a tight public float set up upside as revenue and profitability recover. Valuation is reasonable on an EV/Sales basis, while short interest and low liquidity mean upside can come quic…
Mosaic (MOS) looks attractive after a recent pullback. The stock trades at roughly $23.50 with a market cap near $7.5B, a low price-to-book (~0.61) and EV/EBITDA of ~6.8x. Near-term headwinds have compressed earnings, but structural upside from supply disruptions, tighter phosphate markets, and new asset optionality justify a long-term trade. Entry…
Voyager Technologies is trading with strong momentum after a string of sector- and company-level catalysts. The stock looks actionable as a tactical long while Starlab manufacturing, defense budget tailwinds, and sector backlog growth give tangible mid-term upside. Execution and cash-burn risks keep this a medium-risk trade.
IBM is no longer the sleepy dividend stalwart of old. With watsonx gaining traction, Red Hat/OpenShift contributing meaningful ARR, and a $1 billion federal quantum award that de-risks infrastructure investment, IBM's AI and hybrid-cloud mix is a catalyst for earnings and multiple expansion. I raise my target to $295 and lay out a trade with entry …
Lumentum (LITE) is benefiting from the AI infrastructure squeeze. Surging demand is translating into sizable customer purchase commitments that make near-term revenue visibility cleaner while creating working-capital and cash-flow pressure. I upgrade LITE to Buy on a tactical long-term trade: entry $880.00, target $1085.68, stop $760.00. Time horiz…
Ituran's Q1 headlines - a $0.50 quarterly dividend, $108M cash and no bank debt - alongside solid free cash flow and improving trading momentum give the stock a tactical long setup. Valuation is reasonable for a cash-generative telematics business, but near-term momentum and an elevated RSI mean entries should be disciplined.
Darling Ingredients (DAR) is showing signs of operational recovery after a difficult stretch in renewable fuels. Fundamentals and cash flow remain intact, valuation is reasonable relative to enterprise cash generation, and technicals show a base near the 50-day average. This is a swing trade: enter around $59.00, target the $66.00 52-week high, and…
IonQ's recent technical milestones and a wave of government funding have reignited investor interest. The company's trapped-ion fidelity claim, a potential SkyWater deal for vertical integration cited in coverage, and improving technical indicators support a tactical long. This trade idea outlines a clear entry at $63.60, a stop at $54.00, and a ta…
Baidu is trading at $131 with a $48B market cap and a stretched valuation gap versus its visible AI momentum. Recent partnership wins, a prospective AI chip IPO, and improving technical support argue for a tactical long. This trade lays out entry, stop, targets, time horizon and the key risks that could derail the setup.
Natural Gas Services Group (NGS) is trading at $41.73 with a market cap near $526M and an enterprise value of roughly $763M. With EV/EBITDA about 9.4, P/B ~1.92 and a newly expanded $300M credit facility to fund fleet growth, NGS looks positioned for a re-rating as rental utilization and pricing stabilize. This trade targets a re-rating to a higher…
American Battery Technology (ABAT) appears to have achieved its first positive gross margin, an operational inflection that changes the narrative from pure dilutive funding to early commercial progress. The stock still trades as a small-cap industrial with stretched valuation metrics and ongoing cash burn, so this idea is a tactical long with a cle…
Carlsberg looks like a sensible long trade over the next 45 trading days. The company’s premiumization, disciplined pricing, and cost control should offset headwinds from commodities and FX. Enter at $90.00, stop at $80.00, target $105.00; horizon: mid term (45 trading days).
Bristol-Myers Squibb is quietly positioning for a fresh growth cycle by pairing AI-driven discovery with near-term oncology and neuroscience catalysts. The stock trades at a reasonable multiple, generates robust free cash flow and pays a >4% dividend, making a measured long with defined risk controls attractive for patient, tactical investors.
